Search results 1-1 of 1 in Gastroparesis
Results
-
Rochester, Minn.
View Summary
A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)
Location:
Rochester, Minn.
Trial status:
Open for Enrollment
Why is this study being done?
Heme oxygenase 1 (HO-1) is an enzyme which protects cells from physical, chemical, and biologic stress. In mice with diabetes and slow gastric emptying, hemin increases HO-1 activity and improves gastric emptying. Hemin is produced from red blood cells and is approved by the Food and Drug Administration for treating acute porphyria, which is an inherited condition caused by an enzyme deficiency. Hemin is not approved by the Food and Drug Administration for treating gastroparesis.
NCT ID:
NCT01206582
IRB Number:
09-000129
Who can I contact for additional information about this study?
Rochester: Shannon L Thieke 507-538-3883